Biocept Reports Second Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. SBUX
10. SNDK

Go back to Biocept Reports Second Quarter 2019 Financial Results

Biocept (BIOC) Reports Q2 Loss of $2.70, Revenues Beat

August 12, 2019 4:08 PM EDT

Biocept (NASDAQ: BIOC) reported Q2 EPS of ($2.70), versus ($0.38) reported last year. Revenue for the quarter came in at $1.2 million versus the consensus estimate of $1.02 million.

"I'm pleased to report another quarter of strong performance with revenues increasing 45% over the prior-year quarter, as we continue to execute on our new commercial strategy," said Michael Nall, President and CEO of Biocept. "Growth was driven by a 26% year-over-year increase in commercial samples, as we focused our commercial efforts on segments of the liquid biopsy oncology market where Target Selector can help the most patients, namely in... More